Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm

Details Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm

1996-09-12

1998-11-24

Teng, Sally P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

435 72, 435 691, 530350, 530399, A61K 3817, C12Q 102

Patent

active

058406735

ABSTRACT:
Methods of treating p53-related tumors by administering (1) a modulator of IGF-BP3, wherein the modulator upregulates IGF-BP3 expression or activity, (2) IGF-BP3 itself, or (3) an expression vector comprising a nucleotide sequence encoding IGF-BP3. In the latter method, the IGF-BP3 nucleotide sequence may also be operatively linked to an inducible promoter or enhancer, wherein the method further comprises administering an inducer capable of initiating or upregulating expression of the protein. Furthermore, any of the foregoing methods may include as an additional step administration of a cytotoxic agent. These methods are specific examples of a broader method: treatment of p53-related tumors by inhibiting the binding of IGF to IGFR.

REFERENCES:
patent: 5573925 (1996-11-01), Halazonetis
Baserga et al., Adv. Exp. Med. Biol., vol. 343, pp. 105-112, 1994.
Buckbinder et al., Proc. Natl. Acad. Sci. USA, vol. 91, pp. 10640-10644, 1994.
Cohen et al., Molecular Endocrinology, vol. 7, No. 3, pp. 380-386, 1993.
Cubbage et al., J. Biol. Chem., vol. 265, No. 21, pp. 12642-12649, 1990.
Harrington, et al., The EMBO Journal, vol. 13, No. 14, pp. 3286-3295, 1994.
Baserga, Cell, vol. 79, pp. 927-930, 1994.
Pratt et al., Cancer Research, vol. 53, pp. 5193-5198, 1993.
Sell et al., Cancer Research, vol. 55, pp. 303-306, 1995.
El-Deiry et al., Cell, vol. 75, pp. 817-825, 1993.
Goldring et al., Eukar. Gene Express, vol. 1, pp. 301-321, 1991.
Oh et al., Growth Reg., vol. 3, pp. 113-123, 1993.
Hermeking et al., Science, vol. 265, pp. 2091-2093, 1994.
Moerman et al., Exp. Geronotol., vol. 28, pp. 361-370, 1993.
Grigoriev et al., J. Cell. Physiol., vol. 160, pp. 203-211, 1994.
Buckbinder et al., Nature, vol. 377, pp. 646-649, 1995.
Oh et al., Progress in Growth Factor Research, vol. 6, No. 2-4, pp. 503-512, 1995.
Bertherat, Eur. J. Endocrinol., vol. 134, No. 4 pp. 426-427, 1996.
Ludwig et al., Molecular and Cellular Biology, vol. 16, No. 9, pp. 4952-4960.

Affiliated with

Also associated with

Rating

Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-like growth factor binding protein 3 (IGF-BP3) in treatm will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1702087